TxCell Granted US Orphan Drug Designation for Col-Treg in the Treatment of Chronic Non-Infectious Uveitis
A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017
A first-in-man clinical study is planned to start in 2016, with top line results expected end 2017
Booth G8, Lab Innovations 2015 NEC, Birmingham, UK, 4 - 5 November 2015
The intelligent lab of the future – the special exhibit premiers at LABVOLUTION
System from Quest Diagnostics' products business is first FDA-cleared Herpes Simplex Virus 1 and 2 test that uses genital swab or cerebrospinal fluid (CSF) specimen collection
SCHOTT to present its NEXTREMA® glass-ceramic family and its portfolio of technical glass tubing at DGM Werkstoffwoche
Developed through industry partnerships, the leading platform for all in-vitro screening again raises the bar on efficiency, versatility, and consistency.
Expands GE’s start-to-finish offering for cost efficient manufacture of biopharmaceuticals and increases global access to SSB’s innovative purification technology
PerkinElmer is a leader in preclinical imaging enabling researchers to visualize disease in all its dimensions